Corroborating with this, an antagonist of GPR55, CID16020046, and GPR55−/− knockout mice decreased the pro-inflammatory cytokines in colitis mice models comparable to human inflammatory bowel disease (IBD) [12]. This evidence concerns the gene GPR55 and colitis.